Patents Assigned to REGENERATION THERAPEUTIC INC.
  • PROGENITOR CELLS FROM WHARTON'S JELLY OF HUMAN UMBILICAL CORD
    Publication number: 20170157180
    Abstract: Human progenitor cells are extracted from perivascular tissue of human umbilical cord. The progenitor cell population proliferates rapidly, and harbours osteogenic progenitor cells and MHC?/? progenitor cells, and is useful to grow and repair human tissues including bone.
    Type: Application
    Filed: February 23, 2017
    Publication date: June 8, 2017
    Applicants: Tissue Regeneration Therapeutics Inc., Tissue Regeneration Therapeutics Inc.
    Inventors: John E. DAVIES, Dolores BAKSH, Rahul SARUGASER, Morris HOSSEINI, Antony D.S. LICKORISH
  • Progenitor cells from wharton'S jelly of human umbilical cord
    Patent number: 9611456
    Abstract: Human progenitor cells are extracted from perivascular tissue of human umbilical cord. The progenitor cell population proliferates rapidly, and harbors osteogenic progenitor cells and MHC?/? progenitor cells, and is useful to grow and repair human tissues including bone.
    Type: Grant
    Filed: October 15, 2015
    Date of Patent: April 4, 2017
    Assignee: Tissue Regeneration Therapeutics Inc.
    Inventors: John E. Davies, Dolores Baksh, Rahul Sarugaser, Morris Hosseini, Antony D. S. Lickorish
  • Progenitor cells from Wharton's jelly of human umbilical cord
    Patent number: 9567564
    Abstract: Human progenitor cells are extracted from perivascular tissue of human umbilical cord. The progenitor cell population proliferates rapidly, and harbors osteogenic progenitor cells and MHC?/? progenitor cells, and is useful to grow and repair human tissues including bone.
    Type: Grant
    Filed: May 28, 2013
    Date of Patent: February 14, 2017
    Assignee: Tissue Regeneration Therapeutics Inc.
    Inventors: John E. Davies, Dolores Baksh, Rahul Sarugaser, Morris Hosseini, Antony D. S. Lickorish
  • Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
    Patent number: 9498544
    Abstract: The invention provides methods of preventing or treating diseases or disorders caused by biological agents or chemical agents in a subject (e.g., a mammal, such as a human) by administering genetically modified human umbilical cord perivascular cells.
    Type: Grant
    Filed: March 13, 2015
    Date of Patent: November 22, 2016
    Assignee: Tissue Regeneration Therapeutics Inc.
    Inventors: Jane Elizabeth Ennis, Jeffrey Donald Turner, John Edward Davies
  • Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
    Patent number: 9005599
    Abstract: The invention provides methods of preventing or treating diseases or disorders caused by biological agents or chemical agents in a subject (e.g., a mammal, such as a human) by administering genetically modified human umbilical cord perivascular cells.
    Type: Grant
    Filed: April 20, 2009
    Date of Patent: April 14, 2015
    Assignee: Tissue Regeneration Therapeutics Inc.
    Inventors: Jane Elizabeth Ennis, Jeffrey Donald Turner, John Edward Davies
  • PROGENITOR CELLS FROM WHARTON'S JELLY OF HUMAN UMBILICAL CORD
    Publication number: 20130259840
    Abstract: Human progenitor cells are extracted from perivascular tissue of human umbilical cord. The progenitor cell population proliferates rapidly, and harbours osteogenic progenitor cells and MHC?/? progenitor cells, and is useful to grow and repair human tissues including bone.
    Type: Application
    Filed: May 28, 2013
    Publication date: October 3, 2013
    Applicant: Tissue Regeneration Therapeutics Inc.
    Inventors: John E. Davies, Dolores Baksh, Rahul Sarugaser, Morris Hosseini, Antony D.S. Lickorish
  • Progenitor cells from wharton's jelly of human umbilical cord
    Patent number: 8481311
    Abstract: Human progenitor cells are extracted from perivascular tissue of human umbilical cord. The progenitor cell population proliferates rapidly, and harbors osteogenic progenitor cells and MHC?/? progenitor cells, and is useful to grow and repair human tissues including bone.
    Type: Grant
    Filed: June 11, 2009
    Date of Patent: July 9, 2013
    Assignee: Tissue Regeneration Therapeutics Inc.
    Inventors: John E. Davies, Dolores Baksh, Rahul Sarugaser, Morris Hosseini, Antony D. S. Lickorish
  • POROUS MATERIALS COATED WITH CALCIUM PHOSPHATE AND METHODS OF FABRICATION THEREOF
    Publication number: 20120270031
    Abstract: The present invention relates to a method of coating a porous material such as a medical implant with a layer of calcium phosphate, wherein the material is submersed in an aqueous solution of calcium, phosphate and carbonate ions, and the pH of the solution is gradually increased. A calcium phosphate coating is formed on an internal surface of the porous material by agitating the solution during coating formation.
    Type: Application
    Filed: September 28, 2010
    Publication date: October 25, 2012
    Applicant: REGENERATION THERAPEUTIC INC.
    Inventors: Limin Guan, John E. Davies
  • PROGENITOR CELLS FROM WHARTON'S JELLY OF HUMAN UMBILICAL CORD
    Publication number: 20090269318
    Abstract: Human progenitor cells are extracted from perivascular tissue of human umbilical cord. The progenitor cell population proliferates rapidly, and harbours osteogenic progenitor cells and MHC?/? progenitor cells, and is useful to grow and repair human tissues including bone.
    Type: Application
    Filed: June 11, 2009
    Publication date: October 29, 2009
    Applicant: Tissue Regeneration Therapeutics, Inc.
    Inventors: John E. Davies, Dolores Baksh, Rahul Sarugaser, Morris Hosseini, Antony D.S. Lickorish
  • Progenitor cells from wharton's jelly of human umbilical cord
    Patent number: 7547546
    Abstract: Human progenitor cells are extracted from perivascular tissue of human umbilical cord. The progenitor cell population proliferates rapidly, and harbours osteogenic progenitor cells and MHC?/? progenitor cells, and is useful to grow and repair human tissues including bone.
    Type: Grant
    Filed: October 8, 2004
    Date of Patent: June 16, 2009
    Assignee: Tissue Regeneration Therapeutics Inc.
    Inventors: John E. Davies, Dolores Baksh, Rahul Sarugaser, Morris Hosseini, Antony D. S. Lickorish